EUVIMEDEUVIMED entdecken
Open Access

Metabolomic, proteomic, and transcriptomic changes in adults with epilepsy on modified Atkins diet

Dominique F Leitner iD, Yik Siu, Aryeh Korman, Ziyan Lin, Evgeny Kanshin, Daniel Friedman, Sasha Devore, Beatrix Ueberheide, Aristotelis Tsirigos, Drew R Jones, Thomas Wisniewski iD, Orrin Devinsky iD

Epilepsia · 2023

DOI: 10.1111/epi.17540 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2023. Verfasst von Dominique F Leitner und 11 weiteren Autor:innen. Beteiligte Einrichtung: Comprehensive Epilepsy Center, New York University Grossman School of Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Diet, Ketogenic, Diet, High-Protein Low-Carbohydrate, Epilepsy. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NCI NIH HHS, Dr. Robert C. and Veronica Atkins Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

High‐fat and low‐carbohydrate diets can reduce seizure frequency in some treatment‐resistant epilepsy patients, including the more flexible modified Atkins diet (MAD), which is more palatable, mimicking fasting and inducing high ketone body levels. Low‐carbohydrate diets may shift brain energy production, particularly impacting neuron‐ and astrocyte‐linked metabolism.

Methods

We evaluated the effect of short‐term MAD on molecular mechanisms in adult epilepsy patients from surgical brain tissue and plasma compared to control participants consuming a nonmodified higher carbohydrate diet ( n = 6 MAD, mean age = 43.7 years, range = 21–53, diet for average 10 days; n = 10 control, mean age = 41.9 years, range = 28–64).

Results

By metabolomics, there were 13 increased metabolites in plasma ( n = 15 participants with available specimens), which included 4.10‐fold increased ketone body 3‐hydroxybutyric acid, decreased palmitic acid in cortex ( n = 16), and 11 decreased metabolites in hippocampus ( n = 6), which had top associations with mitochondrial functions. Cortex and plasma 3‐hydroxybutyric acid levels had a positive correlation ( p = .0088, R 2 = .48). Brain proteomics and RNAseq identified few differences, including 2.75‐fold increased hippocampal MT‐ND3 and trends ( p < .01, false discovery rate > 5%) in hippocampal nicotinamide adenine dinucleotide (NADH)‐related signaling pathways (activated oxidative phosphorylation and inhibited sirtuin signaling). Significance Short‐term MAD was associated with metabolic differences in plasma and resected epilepsy brain tissue when compared to control participants, in combination with trending expression changes observed in hippocampal NADH‐related signaling pathways. Future studies should evaluate how brain molecular mechanisms are altered with long‐term MAD in a larger cohort of epilepsy patients, with correlations to seizure frequency, epilepsy syndrome, and other clinical variables. [ Clinicaltrials.gov NCT02565966.]

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diet, KetogenicDiet, High-Protein Low-CarbohydrateEpilepsyHumansAdultInfant, NewbornMiddle AgedTranscriptome3-Hydroxybutyric AcidNADProteomicsDiet, Carbohydrate-RestrictedSeizuresKetone BodiesTreatment Outcome

Stichwörter der Autor:innen

metabolomicsproteomicstranscriptomics

Substanzen

3-Hydroxybutyric AcidNADKetone Bodies

Autor:innen und Institutionen

  • Comprehensive Epilepsy Center, New York University Grossman School of Medicine, New York, New York, USA.
  • Center for Cognitive Neurology, Department of Neurology, New York University Grossman School of Medicine, New York, New York, USA.
  • Department of Neurology, New York University Grossman School of Medicine, New York, New York, USA.
  • Metabolomics Core Resource Laboratory, New York University Grossman School of Medicine, New York, New York, USA.
  • Applied Bioinformatics Laboratories, New York University Grossman School of Medicine, New York, New York, USA.
  • Proteomics Laboratory, Division of Advanced Research Technologies, New York University Grossman School of Medicine, New York, New York, USA.

ORCID-Profile: Dominique F Leitner, Thomas Wisniewski, Orrin Devinsky

Förderung

  • NIA NIH HHS
  • NCI NIH HHS
  • Dr. Robert C. and Veronica Atkins Foundation
  • Finding A Cure for Epilepsy and Seizures
  • NIH Clinical Center

Zitieren

APA

Leitner, D. F., Siu, Y., Korman, A., Lin, Z., Kanshin, E., Friedman, D., Devore, S., Ueberheide, B., Tsirigos, A., Jones, D. R., Wisniewski, T., & Devinsky, O. (2023). Metabolomic, proteomic, and transcriptomic changes in adults with epilepsy on modified Atkins diet. Epilepsia. https://doi.org/10.1111/epi.17540

Vancouver

Leitner DF, Siu Y, Korman A, Lin Z, Kanshin E, Friedman D, et al. Metabolomic, proteomic, and transcriptomic changes in adults with epilepsy on modified Atkins diet. Epilepsia. 2023. doi:10.1111/epi.17540

BibTeX
@article{Leitner2023,
  author = {Leitner, Dominique F and Siu, Yik and Korman, Aryeh and Lin, Ziyan and Kanshin, Evgeny and Friedman, Daniel and Devore, Sasha and Ueberheide, Beatrix and Tsirigos, Aristotelis and Jones, Drew R and Wisniewski, Thomas and Devinsky, Orrin},
  title = {Metabolomic, proteomic, and transcriptomic changes in adults with epilepsy on modified Atkins diet},
  journal = {Epilepsia},
  year = {2023},
  doi = {10.1111/epi.17540}
}
Kostenlos starten →